Full-Year 2025 Financial Highlights
- Full year revenue of $12.5 million, representing a 374% increase compared to 2024, including a one-time revenue contribution of $9.6 million related to the GE settlement discussed below.
- Net loss improved significantly to $5 million, compared to $10 million in 2024.
- $21.7 million in total liquid assets (including $7 million in cash and cash equivalents) as of December 31, 2025.
- Recognized approximately $9.6 million in one-time revenue in connection with a settlement agreement with GE Precision Healthcare LLC (GEHC), which resolved all outstanding disputes between the parties and concluded all related proceedings. Approximately $2.2 million was recognized as revenue from the cancellation of orders placed by GEHC for 15,000 units pursuant to the Settlement Agreement and the termination of the Component Agreement.

